Earnings release
Page 1
Press release IMCD reports EBITA of EUR 285 million (+4%) in the first half of 2026 Rotterdam, The Netherlands (29 July 2026) - IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today announces its first half 2026 results. HIGHLIGHTS • Revenue at EUR 2,638 million (+11% on a constant currency basis) • Gross profit at EUR 658 million (+7% on a constant currency basis) • Operating EBITA at EUR 285 million (+8% on a constant currency basis) • Free cash flow up by 29% to EUR 222 million (first half 2025: EUR 173 million) • Cash earnings per share at EUR 3.18 (first half 2025: EUR 2.94) • Completion of Dong Yang FT (South Korea) and Willows Ingredients (Ireland/UK) acquisitions, with Merit Solution (Thailand) agreement signed Marcus Jordan, CEO: "We have had a positive first half of the year, achieving gross profit and EBITA organic growth alongside increased free cash flow generation. I'm proud of how our teams navigate the dynamic environment whilst maintaining a sharp focus on building long-term partnerships with both our customers and suppliers. We continue to drive forward our commercial, operational and digital excellence initiatives and remain firmly committed to generating long-term value for all stakeholders." KEY FIGURES All financial information in this section is presented in millions of euros, unless stated otherwise. Rounding differences may occur, because the underlying figures are rounded to the nearest million. For the bridges and definitions of the alternative performance measures, reference is made to Appendix A and B of the condensed consolidated interim financial statements for the first half 2026. EUR MILLION JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 CHANGE CHANGE % FX ADJ. CHANGE Revenue 2,638 2,474 164 7% 11% Gross profit 658 634 24 4% 7% Gross profit as a % of revenue 24.9% 25.6% (0.7%) Operating EBITA 285 275 10 4% 8% Operating EBITA as a % of revenue 10.8% 11.1% (0.3%) Conversion margin 43.3% 43.4% (0.1%) Net result 142 130 12 10% 14% Free cash flow 222 173 49 29% Cash conversion margin 76.2% 61.4% 14.8% Earnings per share (EUR) 2.41 2.20 0.21 10% 14% Cash earnings per share (EUR) 3.18 2.94 0.24 8% 13% Number of full-time employees end of period 5,237 5,277 (40) (1%)
Page 2
Revenue In the first half of 2026, revenue increased by 7% to EUR 2,638 million, compared with the same period of 2025 (+11% on a constant currency basis). The revenue increase is the result of organic growth (+3%), the positive impact of the first-time inclusion of acquisitions in 2025 and 2026 (+7%) and negative foreign currency exchange results (-3%). In the second quarter of 2026, revenue increased by 13% compared with the same period of 2025; on a constant currency basis revenue increased by 15%. The second quarter revenue development was driven by organic growth across all regions (+7%), the first-time inclusion of acquisitions completed in 2025 and 2026 (+7%) and negative foreign currency results (-1%). Gross profit Gross profit, defined as revenue less costs of materials and inbound logistics, increased by 4% to EUR 658 million in the first half of 2026, compared with EUR 634 million in the same period of 2025 (+7% on a constant currency basis). The increase in gross profit is the result of organic growth (+2%), the positive impact of the first-time inclusion of acquisitions in 2025 and 2026 (+5%) and negative foreign currency exchange results (-3%). In the second quarter of 2026, organic gross profit growth (+7%), a positive impact of the first-time inclusion of acquisitions (+6%), and negative foreign currency exchange impact (-1%), resulted in a 12% increase in gross profit compared with the same period in 2025. In the first half of 2026, gross profit as a % of revenue was 24.9%, compared with 25.6% in the same period of 2025. The development of the gross profit margin is the result of changes in local market conditions, gross margin improvement initiatives, fluctuations in the product mix and currency exchange rate movements. Additionally, the recently acquired companies had, on average, lower gross profit margins than IMCD, which negatively impacted overall gross profit margins. Operating EBITA In the first half of 2026, operating EBITA increased by 4% to EUR 285 million (+8% on a constant currency basis), compared with EUR 275 million in the same period of 2025. The increase in operating EBITA is driven by organic growth (+1%), the positive impact of the first-time inclusion of acquisitions (+7%) and negative foreign currency exchange rate results (-4%). Following a solid first quarter, the second quarter of 2026 showed a strong operating EBITA increase (+16%), which is the result of positive organic growth in all regions (+11%), the impact of the first-time inclusion of acquisitions (+8%) and negative foreign currency exchange results (-2%). Operating EBITA as a % of revenue decreased by 0.3%-point to 10.8% in the first half of 2026 (first half of 2025: 11.1%). The conversion margin, defined as operating EBITA as a percentage of gross profit, decreased by 0.1%-point to 43.3% in the first half of 2026, from 43.4% in the first half of 2025. 2
Page 3
Cash flow and capital expenditure In the first half of 2026, free cash flow increased by EUR 49 million to EUR 222 million. The cash conversion margin, defined as free cash flow as a percentage of adjusted EBITDA, increased by 14.8%-point to 76.2%, compared with 61.4% in the first half of 2025. The increase in cash conversion margin is mainly attributable to higher adjusted EBITDA (EUR +10.3 million), combined with a reduction in net working capital investments (EUR -37.5 million). The investment in net working capital in the first half of 2026 was EUR 66.0 million compared with EUR 103.5 million in the first half of 2025. At the end of June 2026, net working capital in days of revenue was 70 days (June 2025: 69 days). Working capital days have been adjusted to reflect the impact of acquisitions, as if the acquired entities had been consolidated from 1 January. Capital expenditure was EUR 3.5 million in the first half of 2026 compared with EUR 4.9 million in the same period of 2025. Net debt As at 30 June 2026, net debt was EUR 1,559.6 million compared with EUR 1,551.6 million as at 31 December 2025. The leverage ratio (net debt/operating EBITDA ratio including full year impact of acquisitions) as at the end of June 2026, was 2.8 times EBITDA (31 December 2025: 2.8). The actual leverage, calculated on the basis of the definitions used in the IMCD loan documents, was 2.8 times EBITDA as at the end of June 2026 (31 December 2025: 2.7), which is well below the maximum of 4.25 as allowed under the loan documents. Equity In the first half of 2026, IMCD transferred 12,130 own shares to settle its annual obligations under its long-term incentive plan. As at 30 June 2026, the number of own shares held by IMCD was 63,037 (31 December 2025: 75,167). 3
Page 4
DEVELOPMENTS BY OPERATING SEGMENT The reporting segments are defined as follows: • EMEA: all operating companies in Europe, Türkiye, Israel, United Arab Emirates, Saudi Arabia and Africa • Americas: all operating companies in the United States of America, Canada, Brazil, Puerto Rico, Chile, Argentina, Uruguay, Colombia, Mexico, Peru, Costa Rica, Dominican Republic, Ecuador, Guatemala and El Salvador • Asia-Pacific: all operating companies in Australia, New Zealand, India, Bangladesh, China, Malaysia, Indonesia, Philippines, Thailand, Singapore, Vietnam, Japan, South Korea and Taiwan • Holding companies: all non-operating companies, including the head office in Rotterdam and the regional offices in Singapore and in the United States The developments by operating segment in the first half of 2026 are presented in the following paragraphs. EMEA EUR MILLION JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 CHANGE CHANGE % FX ADJ. CHANGE Revenue 1,225.0 1,065.1 159.9 15% 16% Gross profit 327 .7 293.1 34.6 12% 13% Gross profit as a % of revenue 26.7% 27 .5% (0.8%) Operating EBITA 142.9 124.1 18.8 15% 17% Operating EBITA as a % of revenue 11.7% 11.7% 0.0% Conversion margin 43.6% 42.3% 1.3% In the first half of 2026, revenue increased by 15% to EUR 1,225.0 million, compared with EUR 1,065.1 million in the same period of 2025. The revenue increase of EUR 159.9 million (+16% on a constant currency basis) is driven by organic growth (+5%), the positive impact of the first-time inclusion of acquisitions completed in 2025 and 2026 (+11%), and negative foreign currency exchange results (-1%). Gross profit increased by 12% to EUR 327.7 million in the first half of 2026, compared with EUR 293.1 million in the same period of 2025 (+13% on a constant currency basis). This increase is the result of organic growth (+5%), the positive impact of the first-time inclusion of the acquisitions completed in 2025 and 2026 (+8%), and negative foreign currency exchange results (-1%). Gross profit as a % of revenue decreased by 0.8%-point to 26.7%, from 27.5% in the first half of 2025. Normalised for the impact of acquisitions, the gross profit percentage in 2026 would have been slightly higher than in the first half of 2025. Operating EBITA increased by 15% to EUR 142.9 million, compared with EUR 124.1 million in the first half of 2025. The operating EBITA increase is driven by a combination of organic growth (+7%), the positive impact of the first-time inclusion of acquisitions completed in 2025 and 2026 (+9%), and negative foreign currency exchange results (-1%). Compared with the same period of 2025, operating EBITA as a % of revenue remains stable at 11.7% in the first half of 2026. The conversion margin increased by 1.3%-point to 43.6%, from 42.3% in the first half of 2025. The results of the first half of 2026 include the impact of the acquisitions of Ferrer Alimentación (Spain) in June 2025, TECOM (Spain) in July 2025, Tillmanns (Italy) in December 2025, Willows Ingredients (Ireland/UK) in March 2026, and the insignificant impact of the divestment of Chemimpo South Africa (Pty) Ltd in April 2025. 4
Page 5
Americas EUR MILLION JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 CHANGE CHANGE % FX ADJ. CHANGE Revenue 736.8 769.9 (33.1) (4%) (1%) Gross profit 176.0 191.3 (15.3) (8%) (4%) Gross profit as a % of revenue 23.9% 24.8% (0.9%) Operating EBITA 70.0 83.2 (13.2) (16%) (12%) Operating EBITA as a % of revenue 9.5% 10.8% (1.3%) Conversion margin 39.8% 43.5% (3.7%) In the first half of 2026, revenue decreased by 4% to EUR 736.8 million, compared with EUR 769.9 million in the same period of 2025. The revenue decrease of EUR 33.1 million (-1% on a constant currency basis) is driven by organic decline (-1%), the positive impact of the first-time inclusion of acquisitions completed in 2025 (+1%) and negative foreign currency exchange results (-4%). The Americas segment reported a decrease in gross profit of EUR 15.3 million (-8%) to EUR 176.0 million in the first half of 2026, compared with EUR 191.3 million in the same period of 2025. The decrease in gross profit is the result of organic decline (-5%), the positive impact of the first-time inclusion of the acquisitions completed in 2025 (+1%) and negative foreign currency exchange results (-4%). Gross profit as a % of revenue decreased by 0.9%- point to 23.9%, from 24.8% in the first half of 2025. Operating EBITA was EUR 70.0 million, compared with EUR 83.2 million in the first half of 2025 (-16%). The operating EBITA development is driven by a combination of organic decline (-12%), the positive impact of the first-time inclusion of acquisitions completed in 2025 (+1%) and negative foreign currency exchange results (-4%). Compared with the same period of 2025, operating EBITA as a % of revenue decreased by 1.3%-point to 9.5% in the first half of 2026. The conversion margin decreased by 3.7%-point to 39.8%, from 43.5% in the first half of 2025. The results of the first half of 2026 include the impact of the acquisition of Apus Quimica (Chile) in July 2025. 5
Page 6
Asia-Pacific EUR MILLION JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 CHANGE CHANGE % FX ADJ. CHANGE Revenue 676.6 638.6 38.0 6% 14% Gross profit 154.0 149.9 4.1 3% 11% Gross profit as a % of revenue 22.8% 23.5% (0.7%) Operating EBITA 89.1 86.2 2.9 3% 13% Operating EBITA as a % of revenue 13.2% 13.5% (0.3%) Conversion margin 57 .8% 57 .5% 0.3% In Asia-Pacific, revenue increased by 6% to EUR 676.6 million in the first half of 2026, compared with EUR 638.6 million in the same period of 2025. The revenue increase of EUR 38.0 million (+14% on a constant currency basis) is driven by organic growth (+7%), the positive impact of the first-time inclusion of acquisitions completed in 2025 and 2026 (+7%) and negative foreign currency exchange results (-7%). In the first half of 2026, gross profit increased by 3% to EUR 154.0 million, compared with EUR 149.9 million in the same period of 2025 (+11% on a constant currency basis). This increase is the result of organic growth (+3%), the positive impact of the first-time inclusion of acquisitions completed in 2025 and 2026 (+7%) and negative foreign currency exchange results (-7%). Gross profit as a % of revenue decreased by 0.7%- point to 22.8%, from 23.5% in the first half of 2025. Compared with the same period of 2025, operating EBITA increased by 3% to EUR 89.1 million in the first half of 2026. This increase is the result of a combination of organic growth (+2%), the positive impact of the first-time inclusion of acquisitions completed in 2025 and 2026 (+9%) and negative foreign currency exchange results (-8%). Operating EBITA as a % of revenue decreased by 0.3%-point to 13.2% in the first half of 2026. The conversion margin increased by 0.3%-point to 57.8%, from 57.5% in the first half of 2025. The results of the first half of 2026 include the impact of the acquisition of YCAM (South Korea) in April 2025, Daoqin (China) in May 2025, Trichem (India/Middle East) in June 2025, and Dong Yang (South Korea) in January 2026. Acquisitions On 26 June 2026, IMCD signed an agreement to acquire 100% of the shares in Merit Solution Co., Ltd ("Merit Solution"), a distributor of additives serving the plastics and compounding industry in Thailand. Located in Bangkok, with a team of 24 employees Merit Solution generated revenues of approximately EUR 11 million in 2025. The transaction is subject to customary closing conditions, with anticipated completion in the third quarter of 2026. Holding companies EUR MILLION JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 CHANGE CHANGE % FX ADJ. CHANGE Operating EBITA (17 .1) (18.4) 1.3 (7%) (6%) Operating EBITA in % of total revenue (0.6%) (0.7%) 0.1% Operating EBITA of Holding companies represents costs related to the central head office in Rotterdam as well as the regional head offices in Singapore and the United States. Operating costs decreased by EUR 1.3 million to EUR 17.1 million, compared with EUR 18.4 million in the first half of 2025. 6
Page 7
OUTLOOK IMCD operates in different, often fragmented market segments in multiple geographic regions, connecting many customers and suppliers across a very diverse product range. In general, results are impacted by macroeconomic conditions and developments in specific industries. Results may be affected from period to period by several factors including, the ability to sustain and expand commercial relationships, the ability to introduce new products and start new customer and supplier relationships, and the timing, scope and impact of acquisitions. IMCD’s consistent strategy and resilient business model has led to successful expansion over the years and IMCD remains focused on achieving earnings growth by optimising its services and further strengthening its market positions. Macro-economic and political uncertainty make future developments and demand difficult to predict. However we remain confident that our strong commercial teams, digital and logistic infrastructure and the resilience of our business model, will continue to contribute value to our stakeholders and sustain our growth trajectory. FINANCIAL CALENDAR FINANCIAL CALENDAR 5 November 2026 First nine months 2026 results 19 February 2027 Full year 2026 results 4 March 2027 Annual report 2026 29 April 2027 First three months 2027 results 29 April 2027 Annual General Meeting For further information: Investor Relations T osca Holtland T: +31 (0)10 290 86 53 ir@imcdgroup.com FURTHER INFORMATION Today's analysts call and webcast will start at 9:00 am CET. You can register yourself in advance of the call, by clicking here or to the webcast by clicking here. A recording of this call and webcast will be made available on the IMCD website (www.imcdgroup.com). 7
Page 8
ABOUT IMCD N.V. IMCD N.V. based in Rotterdam, The Netherlands, is a global leading partner for the distribution and formulation of speciality chemicals and ingredients. IMCD is an expert solutions provider and adds sustainable value to the supply chain. Every day professionals focus on providing the best service through commercial and operational excellence. The company is mindful of the role it plays in creating a better planet for all. IMCD formulates with consciousness and executes with care, to address tomorrow's business challenges, through partnership and transparency. In 2025, with over 5,200 employees, IMCD realised revenues of EUR 4,779 million. IMCD N.V.’s shares are traded at Euronext, Amsterdam (symbol: IMCD) and included in the Dutch ESG AEX index, as one of the 25 companies within the AEX and AMX indices demonstrating best ESG practices. For further information, please visit www.imcdgroup.com. Disclaimer forward looking statements This press release may contain forward looking statements. These statements are based on current expectations, estimates and projections of IMCD’s management and information currently available to the company. IMCD cautions that such statements contain elements of risk and uncertainties that are difficult to predict and that could cause actual performance and position to differ materially from these statements. IMCD disclaims any obligation to update or revise any statements made in this press release to reflect subsequent events or circumstances, except as required by law. IMCD N.V.’s most recent annual report outlines the key risk categories and risk factors affecting business and financial performance. As these have not materially changed since that reporting date, they are deemed to be incorporated in this release. This press release contains inside information as meant in clause 7 of the Market Abuse Regulation and was issued on 29 July 2026, 07:00 am CET. 8
Page 9
APPENDIX Operating segment details The tables below present revenue, gross profit and operating EBITA per operating segment, with a breakdown by organic growth, acquisition growth and foreign currency exchange effects. Revenue For the first half of 2026 EUR MILLION JAN. 1 - JUN. 30, 2026 AS A % OF TOTAL JAN. 1 - JUN. 30, 2025 AS A % OF TOTAL ORGANIC ACQUISTION CURRENCY TOTAL EMEA 1,225.0 46.4% 1,065.1 43.1% 4.6% 11.4% (1.0%) 15.0% Americas 736.8 27 .9% 769.9 31.1% (1.4%) 0.8% (3.7%) (4.3%) Asia-Pacific 676.6 25.6% 638.6 25.8% 6.7% 6.7% (7 .4%) 6.0% Total 2,638.4 100.0% 2,473.6 100.0% 3.3% 6.9% (3.5%) 6.7% Revenue For the second quarter of 2026 EUR MILLION APR. 1 - JUN. 30, 2026 AS A % OF TOTAL APR. 1 - JUN. 30, 2025 AS A % OF TOTAL ORGANIC ACQUISTION CURRENCY TOTAL EMEA 637 .4 46.5% 523.9 43.2% 10.3% 11.7% (0.3%) 21.7% Americas 384.0 28.0% 374.2 30.8% 1.6% 0.8% 0.2% 2.6% Asia-Pacific 350.3 25.5% 315.6 26.0% 9.8% 6.0% (4.8%) 11.0% Total 1,371.7 100.0% 1,213.7 100.0% 7 .4% 6.9% (1.3%) 13.0% Gross profit For the first half of 2026 EUR MILLION JAN. 1 - JUN. 30, 2026 AS A % OF REVENUE JAN. 1 - JUN. 30, 2025 AS A % OF REVENUE ORGANIC ACQUISTION CURRENCY TOTAL EMEA 327 .7 26.7% 293.1 27 .5% 5.1% 7 .7% (1.0%) 11.8% Americas 176.0 23.9% 191.3 24.8% (4.7%) 0.5% (3.8%) (8.0%) Asia-Pacific 154.0 22.8% 149.9 23.5% 3.0% 6.9% (7 .1%) 2.8% Total 657 .7 24.9% 634.3 25.6% 1.7% 5.3% (3.3%) 3.7% Gross profit For the second quarter of 2026 EUR MILLION APR. 1 - JUN. 30, 2026 AS A % OF REVENUE APR. 1 - JUN. 30, 2025 AS A % OF REVENUE ORGANIC ACQUISTION CURRENCY TOTAL EMEA 171.2 26.9% 144.0 27 .5% 10.7% 8.5% (0.3%) 18.9% Americas 93.1 24.3% 90.6 24.2% 2.1% 0.6% 0.1% 2.8% Asia-Pacific 81.5 23.3% 74.8 23.7% 7 .0% 6.5% (4.5%) 9.0% Total 345.8 25.2% 309.4 25.5% 7 .3% 5.7% (1.2%) 11.8% 9
Page 10
Operating EBITA For the first half of 2026 EUR MILLION JAN. 1 - JUN. 30, 2026 AS A % OF REVENUE JAN. 1 - JUN. 30, 2025 AS A % OF REVENUE ORGANIC ACQUISTION CURRENCY TOTAL EMEA 142.9 11.7% 124.1 11.7% 7 .3% 9.1% (1.2%) 15.2% Americas 70.0 9.5% 83.2 10.8% (12.3%) 0.7% (4.3%) (15.9%) Asia-Pacific 89.1 13.2% 86.2 13.5% 2.1% 9.4% (8.2%) 3.3% Holding companies (17 .1) (0.6%) (18.4) (0.7%) (5.8%) 0.0% (1.5%) (7 .3%) Total 284.9 10.8% 275.1 11.1% 0.7% 7 .2% (4.3%) 3.6% Operating EBITA For the second quarter of 2026 EUR MILLION APR. 1 - JUN. 30, 2026 AS A % OF REVENUE APR. 1 - JUN. 30, 2025 AS A % OF REVENUE ORGANIC ACQUISTION CURRENCY TOTAL EMEA 77 .0 12.1% 59.7 11.4% 19.8% 9.8% (0.5%) 29.1% Americas 39.1 10.2% 38.1 10.2% 2.2% 0.8% (0.6%) 2.4% Asia-Pacific 48.0 13.7% 44.2 14.0% 5.1% 9.3% (5.8%) 8.6% Holding companies (8.9) (0.7%) (8.8) (0.7%) 2.2% 0.0% (0.4%) 1.8% Total 155.1 11.3% 133.2 11.0% 11.0% 7 .7% (2.3%) 16.4% 10
Page 11
IMCD N.V. CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENT FOR THE FIRST HALF 2026 Condensed consolidated statement of financial position 12 Condensed consolidated statement of financial position (continued) 13 Condensed consolidated statement of profit or loss and comprehensive income 14 Condensed consolidated statement of profit or loss and comprehensive income (continued) 15 Condensed consolidated statement of changes in equity 16 Condensed consolidated statement of cash flows 18 Notes to the condensed consolidated interim financial statements 19 11
Page 12
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION EUR 1,000 NOTE 30 JUNE 2026 31 DECEMBER 2025 Assets Property, plant and equipment 151,956 158,674 Goodwill 1,953,419 1,925,075 Other intangible assets 710,910 732,448 Intangible assets 2,664,329 2,657 ,523 Equity-accounted investees 410 287 Other financial assets 9,840 8,964 Deferred tax assets 11,247 15,277 Non-current assets 2,837 ,783 2,840,725 Inventories 776,456 702,853 T rade and other receivables 1,082,227 853,707 Cash and cash equivalents 248,666 238,587 Current assets 2,107 ,348 1,795,148 Total assets 4,945,131 4,635,872 12
Page 13
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION (CONTINUED) EUR 1,000 NOTE 30 JUNE 2026 31 DECEMBER 2025 Equity 10 Share capital 9,457 9,457 Share premium 1,347 ,091 1,347 ,091 Reserves (273,199) (319,093) Retained earnings 897 ,279 785,848 Unappropriated result 142,340 217 ,578 Total shareholders' equity 2,122,968 2,040,882 Non-controlling interest 1,317 1,296 Total equity 2,124,286 2,042,177 Liabilities Loans and borrowings 11 1,074,262 1,378,109 Employee benefits 19,228 19,458 Provisions 21,526 19,470 Deferred tax liabilities 141,930 141,758 Total non-current liabilities 1,256,947 1,558,796 Loans and borrowings 11 375,000 325,000 Short-term financial liabilities 11 359,033 87 ,104 T rade payables 648,306 441,606 Other payables 181,560 181,189 Total current liabilities 1,563,898 1,034,899 Total liabilities 2,820,845 2,593,695 Total equity and liabilities 4,945,131 4,635,872 13
Page 14
CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND COMPREHENSIVE INCOME EUR 1,000 NOTE JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 Revenue 6 2,638,420 2,473,639 Other income 16,795 12,488 Operating income 2,655,216 2,486,127 Cost of materials and inbound logistics (1,980,726) (1,839,341) Cost of warehousing, outbound logistics and other services (84,421) (77 ,276) Wages and salaries (172,013) (170,954) Social security and other charges (47 ,373) (46,244) Depreciation of property, plant and equipment (21,503) (20,464) Amortisation of intangible assets (52,479) (49,718) Other operating expenses (65,229) (63,860) Operating expenses (2,423,743) (2,267 ,857) Result from operating activities 231,472 218,270 Finance income 4,241 14,269 Finance costs (39,670) (58,506) Net finance costs 7 (35,429) (44,237) Share of profit of equity-accounted investees, net of tax 119 147 Result before income tax 196,162 174,180 Income tax expense (53,801) (44,501) Result for the period 142,361 129,679 Result for the period attributable to the shareholders of the Company 142,340 129,711 Result for the period attributable to non-controlling interest 22 (32) Result for the period 142,361 129,679 Weighted average number of shares 59,043,744 59,071,671 Basic earnings per share in EUR 2.41 2.20 Diluted earnings per share in EUR 2.41 2.19 Gross profit1 657 ,694 634,298 Gross profit as a % of revenue 24.9% 25.6% Operating EBITA1 4 284,943 275,084 Operating EBITA as a % of revenue 10.8% 11.1% 1 For the bridges and definitions of the alternative performance measures, reference is made to Appendix A and B. 14
Page 15
CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND COMPREHENSIVE INCOME (CONTINUED) EUR 1,000 NOTE JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 Result for the period 142,361 129,679 Defined benefit plan actuarial gains/(losses) (135) (364) Related tax 29 88 Items that will never be reclassified to profit or loss (106) (276) Foreign currency translation differences related to foreign operations 46,654 (235,098) Related tax (1,288) (29) Items that are or may be reclassified to profit or loss 45,366 (235,127) Other comprehensive income for the period, net of income tax 45,260 (235,403) Total comprehensive income for the period 187 ,622 (105,724) Attributable to: Shareholders of the Company 187 ,600 (105,692) Non-controlling interests 22 (32) Total comprehensive income for the period 187 ,622 (105,724) 15
Page 16
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY EUR 1,000 NOTE SHARE CAPITAL SHARE PREMIUM TRANSLATION RESERVE HEDGING RESERVE RESERVE OWN SHARES OTHER RESERVES RETAINED EARNINGS UNAPPRO- PRIATED RESULT TOTAL SHAREHOLDERS' EQUITY NON- CONTROLLING INTEREST TOTAL EQUITY Balance as at 1 January 2026 9,457 1,347 ,091 (324,916) (107) (9,501) 15,431 785,848 217 ,578 2,040,882 1,296 2,042,177 Appropriation of prior year’s result - - - - - - 110,709 (110,709) - - - 9,457 1,347 ,091 (324,916) (107) (9,501) 15,431 896,557 106,869 2,040,882 1,296 2,042,177 Result for the period - - - - - - - 142,340 142,340 22 142,361 T otal other comprehensive income - - 45,366 - - (106) - - 45,260 - 45,260 Total comprehensive income for the period - - 45,366 - - (106) - 142,340 187 ,600 22 187 ,622 Cash dividend 10 - - - - - - - (106,869) (106,869) - (106,869) Share based payments - - - - - (959) 1,282 - 322 - 322 Purchase and transfer own shares 10 - - - - 1,593 - (560) - 1,033 - 1,033 Total contributions by and distributions to owners of the Company - - - - 1,593 (959) 722 (106,869) (105,513) - (105,513) Balance as at 30 June 2026 9,457 1,347 ,091 (279,550) (107) (7 ,908) 14,366 897 ,279 142,340 2,122,968 1,317 2,124,286 16
Page 17
EUR 1,000 NOTE SHARE CAPITAL SHARE PREMIUM TRANSLATION RESERVE HEDGING RESERVE RESERVE OWN SHARES OTHER RESERVES RETAINED EARNINGS UNAPPRO- PRIATED RESULT TOTAL SHAREHOLDERS' EQUITY NON- CONTROLLING INTEREST TOTAL EQUITY Balance as at 1 January 2025 9,457 1,347 ,075 (65,803) (54) (5,064) 15,373 634,492 278,243 2,213,720 1,375 2,215,095 Appropriation of prior year’s result - - - - - - 151,213 (151,213) - - - 9,457 1,347 ,075 (65,803) (54) (5,064) 15,373 785,705 127 ,030 2,213,720 1,375 2,215,095 Result for the period - - - - - - - 129,711 129,711 (32) 129,679 T otal other comprehensive income - - (235,127) - - (276) - - (235,403) - (235,403) Total comprehensive income for the period - - (235,127) - - (276) - 129,711 (105,692) (32) (105,724) Cash dividend 10 - - - - - - - (127 ,030) (127 ,030) - (127 ,030) Share based payments - - - - - (1,200) 70 - (1,130) - (1,130) Purchase and transfer own shares 10 - - - - (4,437) - 68 - (4,369) - (4,369) Total contributions by and distributions to owners of the Company - - - - (4,437) (1,200) 138 (127 ,030) (132,529) - (132,529) Balance as at 30 June 2025 9,457 1,347 ,075 (300,929) (54) (9,501) 13,897 785,843 129,711 1,975,499 1,343 1,976,842 17
Page 18
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS EUR 1,000 NOTE JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 Cash flows from operating activities Result for the year 142,361 129,679 Adjustments for: • Depreciation of property, plant and equipment 21,503 20,464 • Amortisation of intangible assets 52,479 49,718 • Net finance costs excluding currency exchange results 7 33,286 23,015 • Currency exchange results 7 2,144 21,222 • Cost of share based payments 1,967 2,305 • Share of profit of equity-accounted investees, net of tax (119) 37 • Income tax expense 53,801 44,501 307 ,421 290,941 Change in: • Inventories (41,240) (69,889) • T rade and other receivables (198,133) (145,792) • T rade and other payables 173,386 112,204 • Provisions and employee benefits (541) (1,140) Cash generated from operating activities 240,892 186,324 Interest paid (32,537) (27 ,167) Income tax paid (39,322) (51,829) Net cash from operating activities 169,034 107 ,328 Cash flows from investing activities Payments for acquisition of subsidiaries, net of cash acquired and divestures 5, 12 (49,587) (239,335) Acquisition of intangible assets (5,004) (4,016) Acquisition of property, plant and equipment (5,468) (4,924) Proceeds from disposals of (in)tangible assets 2,243 - Acquisition of other financial assets (894) (104) Net cash used in investing activities (58,709) (248,379) Cash flows from financing activities Dividends paid 10 (106,869) (127 ,030) Purchase of own shares - (6,201) Share based payments (695) (1,501) Payment of transaction costs related to loans and borrowings (468) (3) Movements in bank loans and other short-term financial liabilities 11, 12 11,881 52,566 Proceeds from issue of current and non-current loans and borrowings 140,809 318,000 Repayment of loans and borrowings 11, 12 (122,658) (385,821) Repayment of lease liabilities (16,325) (15,489) Net cash from / (used in) financing activities (94,326) (165,479) Net increase in cash and cash equivalents 15,999 (306,530) Cash and cash equivalents as at 1 January 238,587 525,380 Effect of exchange rate fluctuations (5,920) (28,424) Cash and cash equivalents as at 31 December 248,666 190,426 18
Page 19
NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS 1. Reporting entity IMCD N.V. (the ‘Company’) is a public limited company domiciled in The Netherlands and registered in The Netherlands Chamber of Commerce Commercial register under number 21740070. The address of the Company’s registered office is Wilhelminaplein 32, Rotterdam. The condensed consolidated interim financial statements of the Company as at and for the first half year ended 30 June 2026, comprise the Company and its subsidiaries (together referred to as the ‘Group’ and individually as ‘Group entities’). The Company is acting as the parent company of the IMCD group, a global leading partner for the distribution and formulation of speciality chemicals and ingredients. The Group has offices in Europe, Africa, North and Latin America and Asia-Pacific. 2. Basis of preparation Statement of compliance The condensed consolidated interim financial statements have been prepared in accordance with IAS 34 “Interim Financial Reporting” as issued by the International Accounting Standards Board (IASB) and interpretations of the IFRS Interpretations Committee (IFRIC) as adopted by the European Union (EU). They do not include all the information as required for a complete set of IFRS annual financial statements and should be read in conjunction with the audited consolidated financial statements as at and for the year ended 31 December 2025. Selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in the Group’s financial position and performance since the last audited consolidated financial statements as at and for the year ended 31 December 2025. The condensed consolidated interim financial statements were prepared by the Management Board and were authorised for issue by the Supervisory Board on 28 July 2026. Functional and presentation currency The condensed consolidated interim financial statements are presented in Euro, which is the Company’s functional currency. All financial information presented in Euro has been rounded to the nearest thousand, unless mentioned differently. Use of estimates and judgements In preparing the condensed consolidated interim financial statements, management makes judgements, estimates and assumptions that affect the application of accounting policies and the reported amount of assets and liabilities income and expense. Actual results may differ from these estimates. The significant judgements made by management in applying the Group’s accounting policies and the key sources of estimation uncertainty are the same as those applied to the Group's audited consolidated financial statements as at and for the year ended 31 December 2025. Risk management The key risk categories and factors that could significantly impact IMCD’s financial position and results are outlined in the IMCD Annual Report 2025 (see pages 138–145). These risks are expected to remain relevant throughout the second half of 2026 and have therefore been incorporated into this report. A comprehensive update of the company's material risks will be provided in the 2026 Annual Report, scheduled for publication in March 2027. 19
Page 20
Going concern The condensed interim consolidated financial statements have been prepared on a going concern basis. 3. Changes in accounting policies and methods of computation The accounting policies and methods of computation applied in these interim financial statements are the same as those applied in the Group's audited consolidated financial statements as at and for the year ended 31 December 2025. A number of amended standards are effective from 1 January 2026 and did not have a material effect on the Company's condensed consolidated interim financial statements. The Company has not early-adopted any standard, interpretation or amendment that has been issued but is not yet effective and endorsed. 4. Operating segments In presenting information on the basis of operating segments, segment revenue is based on the geographical location of customers. Segment assets are based on the geographical location of the assets with the exception of assets related to holding companies, which are presented in a separate reporting unit. The reporting segments used are defined as follows: • EMEA: all operating companies in Europe, Türkiye, Israel, United Arab Emirates, Saudi Arabia and Africa • Americas: all operating companies in the United States of America, Canada, Brazil, Puerto Rico, Chile, Argentina, Uruguay, Colombia, Mexico, Peru, Costa Rica and Dominican Republic, Ecuador, Guatemala and El Salvador • Asia-Pacific: all operating companies in Australia, New Zealand, India, Bangladesh, China, Singapore, Malaysia, Indonesia, Philippines, Thailand, Vietnam, Japan, South Korea and Taiwan • Holding companies: all non-operating companies, including the head office in Rotterdam and the regional offices in Singapore and in the United States. EMEA EUR 1,000 JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 Revenue 1,225,001 1,065,108 Gross profit 327 ,685 293,082 Operating EBITA 142,929 124,075 Result from operating activities 124,727 106,597 T otal assets 1,689,016 1,399,836 T otal liabilities 524,150 433,790 Americas EUR 1,000 JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 Revenue 736,796 769,905 Gross profit 175,980 191,324 Operating EBITA 70,010 83,208 Result from operating activities 58,864 67 ,808 T otal assets 980,448 940,279 T otal liabilities 278,631 261,907 20
Page 21
Asia-Pacific EUR 1,000 JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 Revenue 676,623 638,626 Gross profit 154,029 149,893 Operating EBITA 89,069 86,161 Result from operating activities 70,480 61,538 T otal assets 1,761,041 1,765,690 T otal liabilities 310,014 335,065 Holding companies EUR 1,000 JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 Operating EBITA (17 ,065) (18,362) Result from operating activities (22,599) (17 ,673) T otal assets 514,626 520,387 T otal liabilities 1,708,051 1,618,589 Consolidated EUR 1,000 JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 Revenue 2,638,420 2,473,639 Gross profit 657 ,694 634,298 Operating EBITA 284,943 275,084 Result from operating activities 231,472 218,270 Equity 2,124,286 1,976,842 T otal assets 4,945,131 4,626,192 T otal liabilities 2,820,845 2,649,350 21
Page 22
5. Business combinations On 15 January 2026, IMCD acquired 100% of the shares in Dong Yang FT Corp. ("Dong Yang FT"). Dong Yang FT is a distributor of high-quality cosmetic ingredients, working with cosmetic manufacturers across the beauty and personal care sector in South Korea. With a team of 14 members and an R&D laboratory, Dong Yang FT generated revenues of approximately EUR 32 million in 2025. On 19 March 2026, IMCD acquired 100% of the shares in Willows Ingredients Group Limited ("Willows Ingredients"), a distributor of ingredients serving the food and nutrition sector with expertise in health, sports and animal nutrition, operating predominantly across Ireland and the UK. In 2025, Willows Ingredients, headquartered in Ireland, generated revenues of approximately EUR 30 million, with a team of 36 members. The two transactions completed in the first half of 2026, added EUR 28.3 million of revenue and EUR 3.0 million of result for the period to the Group’s results in 2026. If the acquisitions had occurred on 1 January 2026, management estimates that the consolidated revenue would have been EUR 2,645.9 million and the consolidated result for the period would have been EUR 142.9 million in the first half of 2026. In determining these amounts, management has assumed that the fair value adjustments, determined provisionally, that arose on the date of acquisition would have been the same if the acquisitions had occurred on 1 January 2026. In addition to the transactions completed during the period, on 26 June 2026 IMCD signed an agreement to acquire 100% of the shares in Merit Solution Co., Ltd ("Merit Solution"), a distributor of additives serving the plastics and compounding industry in Thailand. Located in Bangkok, with a team of 24 employees, Merit Solution generated revenues of approximately EUR 11 million in 2025. The transaction is subject to customary closing conditions and is expected to close in the third quarter of 2026. Identifiable assets recognised and liabilities assumed The recognised amounts of assets acquired and liabilities assumed, based on the provisional purchase price allocation at the acquisition dates of the acquisitions completed in the first half of 2026, are presented below. In accordance with IFRS 3, the Group has up to 12 months from the acquisition date to finalise the purchase price allocation. Accordingly, the reported fair values of the acquired assets and liabilities, as well as the resulting goodwill, may be subject to change during this period. EUR 1,000 TOTAL Property, plant and equipment 623 Intangible assets 8,862 Deferred tax assets 509 Other financial assets 103 Inventories 22,406 T rade and other receivables 7 ,622 Cash and cash equivalents 7 ,713 Loans and borrowings (432) Other short-term financial liabilities (3,835) Employee benefits and other provisions (2,090) Deferred tax liabilities (1,462) T rade payables and other payables (10,593) Total identifiable net assets 29,427 22
Page 23
The reconciliation between the total consideration paid for acquisitions and received from divestments, and the cash flow line item "Payment for acquisition of subsidiaries, net of cash acquired and divestitures" is presented below. CONSIDERATION BRIDGE TOTAL T otal consideration 44,583 Acquired cash (7 ,713) Deferred at closing (5,451) Other deferred considerations paid during the year 18,168 Payments for acquisition of subsidiaries, net of cash acquired and divestures 49,587 Goodwill The goodwill recognised as a result of the acquisitions is as follows. EUR 1,000 TOTAL T otal consideration, including deferred and contingent considerations 44,583 Less: fair value of identifiable net assets 29,427 Goodwill 15,156 The goodwill is mainly attributable to the skills and technical talent of the work force, the international network and the synergies expected to be achieved from integration of acquired companies into the Group’s existing distribution business. 6. Revenue The Group generates revenue primarily from the sale and distribution of speciality chemicals and ingredients. Other sources of revenue include revenue from commission where the Group acts as agent in the sale and distribution of speciality chemicals and ingredients. EUR 1,000 JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 Sales of goods 2,631,665 2,468,151 Commissions 6,755 5,488 Total revenue 2,638,420 2,473,639 In the following tables, revenue from contracts with customers is disaggregated by primary geographical market and by market segments, namely Life Science and Industrial. Geographical markets The breakdown of revenue by geographical market is as follows. EUR 1,000 JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 The Netherlands 53,641 41,897 Rest of EMEA 1,171,360 1,023,211 EMEA 1,225,001 1,065,108 North America 481,039 514,570 Latin America 255,757 255,335 Americas 736,796 769,905 Asia-Pacific 676,623 638,626 Total revenue 2,638,420 2,473,639 23
Page 24
Market segments IMCD's business model is based on long-lasting relationships with suppliers of speciality chemicals and ingredients. To provide enhanced transparency regarding market segmentation, IMCD presents its sales split across the two market segments: Life Science and Industrial. Life Science consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition and Home Care and Industrial & Institutional. In general, the lines of business within Life Science historically have been less sensitive to economic fluctuations. Furthermore, the Life Science segment generally involves lower order volumes and higher margins than the Industrials market segment. The Industrial segment contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. This segment has a more cyclical nature as the performance is dependent on the developments of, amongst others, the housing and real estate, automotive and oil & gas markets. The breakdown of sales of goods per market segment is as follows: EUR 1,000 JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 Life Science 1,426,842 1,331,019 Industrial 1,204,823 1,137 ,132 Total Market Segments 2,631,665 2,468,151 7 . Net finance costs The net finance costs in the first half of 2026 consist of the following items. EUR 1,000 JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 Interest income on loans and receivables 2,672 2,095 Changes in contingent considerations 1,569 12,174 Finance income 4,241 14,269 Interest expenses on financial liabilities measured at amortised cost (34,560) (29,731) Interest expenses on provisions for pensions and similar obligations (231) (244) Interest expenses on lease liabilities (2,383) (2,397) Changes in contingent considerations (352) (4,911) Hyperinflation loss on net monetary position (4,512) (2,262) Currency exchange results 2,368 (18,960) Finance costs (39,670) (58,506) Net finance costs recognised in profit or loss (35,429) (44,237) In the first half of 2026, net finance costs were EUR 35.4 million, compared with EUR 44.2 million in the same period of 2025. The decrease in net finance costs was primarily driven by positive currency exchange results of EUR 2.4 million, compared with a negative foreign exchange results of EUR 19.0 million in the same period of 2025, resulting in a favourable year-on-year impact of EUR +21.4 million. This benefit was partly offset by decreased gains from changes in contingent considerations (EUR -6.1 million), an increase in external interest expenses (EUR -4.8 million), and a higher hyperinflation loss (EUR -2.2 million). 24
Page 25
8. Acquisition costs and results related to one-off adjustments to the organisation Acquisition costs and results related to one-off adjustments to the organisation are recognised in profit or loss and are summarised as follows. EUR 1,000 JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 Other income 4,480 - Personnel expenses and other operating expenses (5,472) (7 ,096) Impact on result before income tax (992) (7 ,096) Acquisition costs/one-off adjustments income tax expenses 1,118 668 Impact on result for the period 126 (6,428) Acquisition costs and results related to one-off adjustments to the organisation include a gain of EUR 4.5 million on the sale of a warehouse (2025: nil), personnel expenses related to organisational adjustments of EUR 2.6 million (2025: EUR 3.4 million), and other operating expenses of EUR 2.8 million (2025: 3.7 million), predominantly related to acquisitions. 9. Seasonality of operations The Group is generally not exposed to significant seasonal fluctuations, although trading activity may be slightly lower during holiday periods in certain regions. 10. Equity Following the decision about the appropriation of the financial result 2025 by the Annual General Meeting of 30 April 2026, the Company distributed a dividend in cash of EUR 106.9 million (EUR 1.81 per share). In 2025, the Company distributed a dividend in cash of EUR 127.0 million (EUR 2.15 per share). In the first half of 2026, IMCD transferred 12,130 own shares to settle its annual obligations under its long-term incentive plan. As at 30 June 2026, the number of own shares held by IMCD was 63,037 (31 December 2025: 75,167). 11. Loans and borrowings As at 30 June 2026, net debt was EUR 1,559.6 million (31 December 2025: EUR 1,551.6 million). The leverage ratio (net debt/operating EBITDA ratio including full year impact of acquisitions) as at the end of June 2026, was 2.8 times EBITDA (31 December 2025: 2.8). The actual leverage, calculated on the basis of the definitions used in the IMCD loan documents, was 2.8 times EBITDA at the end of June 2026 (31 December 2025: 2.7), which is well below the maximum of 4.25 as allowed under the loan documents. On 27 January 2026, IMCD increased its revolving credit facility by EUR 100 million to EUR 700 million and obtained additional financing flexibility through amended facility terms. 25
Page 26
12. Financial instruments Accounting classifications and fair values The following table shows the carrying amounts and fair values of financial assets and financial liabilities, including their levels in the fair value hierarchy. It does not include fair value information for financial assets and financial liabilities not measured at fair value if the carrying amount is a reasonable approximation of fair value. 30 JUNE 2026 CARRYING AMOUNT FAIR VALUE EUR 1,000 FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS AMORTISED COST FINANCIAL LIABILITIES AT FAIR VALUE THROUGH PROFIT OR LOSS TOTAL LEVEL 1 LEVEL 2 LEVEL 3 TOTAL Forward exchange contracts used for hedging 646 - - 646 - 646 - 646 Forward exchange contracts used for hedging - - 663 663 - 663 - 663 Contingent consideration - - 23,363 23,363 - - 23,363 23,363 31 DECEMBER 2025 CARRYING AMOUNT FAIR VALUE EUR 1,000 FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS AMORTISED COST FINANCIAL LIABILITIES AT FAIR VALUE THROUGH PROFIT OR LOSS TOTAL LEVEL 1 LEVEL 2 LEVEL 3 TOTAL Forward exchange contracts used for hedging 52 - - 52 - 52 - 52 Forward exchange contracts used for hedging - - 932 932 - 932 - 932 Contingent consideration - - 36,461 36,461 - - 36,461 36,461 Measurement of fair values The following tables show the valuation techniques used in measuring Level 2 and Level 3 fair values, as well as the significant unobservable inputs used. Financial instruments measured at fair value TYPE VALUATION TECHNIQUE SIGNIFICANT UNOBSERVABLE INPUTS INTER-RELATIONSHIP BETWEEN SIGNIFICANT UNOBSERVABLE INPUTS AND FAIR VALUE MEASUREMENT Contingent consideration Discounted cash flows: The valuation model considers the present value of expected payment, discounted using a risk-adjusted discount rate. The expected payment is determined by considering the possible scenarios of forecast EBITDA, the amount to be paid under each scenario and the probability of each scenario. • Forecast EBITDA margin • Risk-adjusted discount rate The estimated fair value would increase/(decrease) if: • The EBITDA margins were higher/ (lower); or • The risk-adjusted discount rates were lower/(higher). Forward exchange contracts and interest rate swaps Market comparison technique: The fair values based on quotes acquired from financial institutions. Similar contracts are traded in an active market and the quotes reflect the actual transactions in similar instruments. Not applicable Not applicable Financial instruments not measured at fair value TYPE VALUATION TECHNIQUE - FOR THE DISCLOSURE SIGNIFICANT UNOBSERVABLE INPUTS Financial assets1 Discounted cash flows Not applicable Financial liabilities2 Discounted cash flows Not applicable 1 Financial assets include trade and other receivables and cash and cash equivalents. 2 Financial liabilities include syndicated senior bank loans, other loans and borrowings, other short term financial liabilities, trade payables and other payables. 26
Page 27
Level 3 fair values The following table shows the reconciliation from the opening balances to the closing balances for level 3 values. EUR 1,000 NOTE 30 JUNE 2026 31 DECEMBER 2025 Balance as at 1 January 36,461 98,555 Assumed in a business combination 5 5,451 25,799 Paid contingent consideration (18,168) (66,926) Loss/(gain) included in profit or loss (1,217) (14,627) Effect of movement in exchange rates 837 (6,341) Balance as at the end of the period 23,363 36,461 The amount assumed in business combinations relates to the deferred purchase prices for the acquisitions of Dong Yang and Willows Ingredients. The net gain included in profit or loss of EUR 1.2 million (full year 2025: gain of EUR 14.6 million) is the result of remeasuring contingent considerations, and interest costs related to the deferred considerations. These remeasurement adjustments reflect differences between the actual profitability of the acquired entities and the assumptions made in the previous fair value assessment, potentially leading to upward or downward revisions. 13. Related parties The Group has related party relationships with its shareholders, associates, Management Board, Supervisory Board, and post-employment benefit plans. The related party transactions during the first half of 2026 do not materially deviate from those disclosed in IMCD's financial statements as at and for the year ended 31 December 2025. 14. Subsequent events No subsequent events have occurred. 15. Auditor's review The condensed consolidated interim financial statements for the first half of 2026 have not been audited nor reviewed by the external auditor. 16. Responsibility statement The Management Board of IMCD N.V. hereby declares that, to the best of its knowledge: • the Interim Consolidated Financial Information for the first half of 2026, prepared in accordance with IAS 34 Interim Financial Reporting as adopted by the European Union, gives a true and fair view of the assets, liabilities, financial position, and profit or loss of IMCD N.V. and its consolidated subsidiaries as a whole; and • the semi-annual report provides a fair review of the information required pursuant to Section 5:25d, subsections 8 and 9 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). Rotterdam, 28 July 2026 Management Board: M.C. Jordan, CEO H.J.J. Kooijmans, CFO A.C. Igerl, COO 27
Page 28
APPENDIX A Reconciliation APMs Bridge operating EBITA to result for the period EUR MILLION JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 Operating EBITA 284.9 275.1 Amortisation of intangible assets (52.5) (49.7) Acquisition costs and results related to one-off adjustments to the organisation (1.0) (7 .1) Result from operating activities 231.5 218.3 Net finance costs (35.4) (44.2) Share of profit of equity-accounted investees, net of tax 0.1 0.1 Result before income tax 196.2 174.2 Recurring income tax expenses (54.9) (45.2) Net tax income on acquisition costs and results related to one-off adjustments to the organisation 1.1 0.7 Result for the period 142.4 129.7 Acquisition costs and results related to one-off adjustments to the organisation include a gain of EUR 4.5 million on the sale of a warehouse (first half 2025: nil), personnel expenses related to organisational adjustments of EUR 2.6 million (first half 2025: EUR 3.4 million), and predominantly acquisition-related expenses of EUR 2.8 million (first half 2025: 3.7 million). The increase in recurring income tax expenses is primarily attributable to a higher profit before income tax and the recognition of tax losses in the prior year. Gross profit EUR MILLION JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 Revenue 2,638.4 2,473.6 Cost of materials and inbound logistics (1,980.7) (1,839.3) Gross profit 657 .7 634.3 Free cash flow EUR MILLION JAN. 1 - JUN. 30, 2026 JAN. 1 - JUN. 30, 2025 Operating EBITA 284.9 275.1 Depreciation of property, plant and equipment 21.5 20.5 Operating EBITDA 306.4 295.5 Lease payments (17 .1) (16.9) Share based payments 2.0 2.3 Adjusted EBITDA 291.3 281.0 Change in: Inventories (41.2) (69.9) T rade and other receivables (198.1) (145.8) T rade and other payables 173.4 112.2 Change operational working capital (66.0) (103.5) Acquisition of property, plant and equipment (5.8) (6.0) Proceeds from disposals of tangible assets 2.3 1.1 Free cash flow 221.9 172.6 Cash conversion margin 76.2% 61.4% 28
Page 29
APPENDIX B Alternative performance measures (APMs) In presenting and discussing the financial position, operating results and net results and cash generation, certain alternative performance measures (APMs) are used. APMs - also known as non-IFRS measures - are financial metrics used by IMCD management to monitor the company's performance and are disclosed to provide additional insights into its performance beyond what is reported using standard accounting principles. APM DESCRIPTION PURPOSE FOR IMCD Adjusted leverage ratio Net debt divided by last twelve months EBITDA, whereby EBITDA includes the pre-closing EBITDA for businesses acquired year-to-date The adjusted leverage ratio measures the net debt relative to EBITDA, including pre-closing EBITDA for acquisitions completed year-to-date. This metric helps to manage debt levels and maintain financial resilience. Adjusted EBITDA Operating EBITDA plus non-cash share-based payment costs minus lease payments IMCD uses adjusted EBITDA to monitor operational performance and for strategic decision making and is also used for calculating the cash conversion margin. Cash conversion margin Free cash flow as a percentage of adjusted operating EBITDA Cash conversion margin measures the ability of converting operational results into cash. Cash earnings per share Result for the year before amortisation (net of tax) divided by the weighted average number of outstanding shares IMCD uses cash earnings per share for monitoring profitability per share, correcting for the impact of the non-cash amortisation expenses and hence providing an indication for the cash generation per share. Central cost allocation charges The costs charged out by the head office to operating companies worldwide for costs incurred centrally on behalf of the wider group Central cost allocation is used to ensure a fair share of head office service costs is allocated to the group entities. Constant currency basis Historical results translated at current year's foreign currency exchange rates IMCD uses constant currency basis to eliminate currency fluctuation effects when comparing current year's results with last year results. Conversion margin Operating EBITA as a percentage of gross profit IMCD uses the conversion margin to manage operational efficiency and cost management. EBITA Result from operating activities before amortisation of intangible assets, and before acquisition costs and results related to one-off adjustments to the organisation EBITA and EBITDA are metrics used by IMCD and its peers in the market to evaluate and manage its operational performance. EBITDA Result from operating activities before depreciation of property plant and equipment, amortisation of intangible assets, and before acquisition costs and results related to one-off adjustments to the organisation Free cash flow Operating EBITDA excluding non-cash share-based payment expenses, less lease payments, plus/less changes in working capital, less capital expenditures IMCD uses free cash flow as a performance indicator for operational cash generation. Free cash flow provides insight into the available funds for financing related payments, tax payments, distribution of dividends and for funding strategic initiatives. Gross profit Revenue minus costs of materials and inbound logistics IMCD uses Gross Profit and the Gross Profit % to measure profitability to assess commercial performance and support sustainable growth. Gross profit % Gross profit as a percentage of revenue Leverage ratio Net debt divided by last twelve months EBITDA The leverage ratio is used to assess the financial health and risks of the group, and supports investment and financing decisions. Net capital expenditure Acquisition of property, plant and equipment minus proceeds from disposals of property, plant and equipment Net capital expenditure supports IMCD to effectively manage and optimise capital spending for funding and strategic initiatives. Net debt The total of current and non-current loans and borrowings, short term financial liabilities minus cash and cash equivalents Net debt is used to manage liquidity effectively and assess financial risks accurately, ensuring financial resilience. Operating EBITA EBITA excluding central cost allocation charges (on consolidated level equal to EBITA) Operating EBITA and Operating EBITDA are measures that IMCD uses to evaluate its operational profitability and analyse operational performance. In these metrics the impacts of central cost allocation charges are excluded. Operating EBITDA EBITDA excluding central cost allocation charges (on consolidated level equal to EBITDA) 29
Page 30
APM DESCRIPTION PURPOSE FOR IMCD Operational working capital Working capital excluding accrued interest expenses and excluding current tax liabilities Operational working capital is used in managing short-term liquidity, cost optimisation and managing operational risks. Organic growth/decline The change in results compared with the prior period, excluding (i) the contribution of acquired businesses during the first 12 months following their acquisition date and (ii) the impact of foreign currency exchange rate fluctuations. Organic growth/decline, which excludes the impacts of acquisitions and currency fluctuations, provides insight into IMCD's core business performance. Own cost Cost (excluding acquisition costs and results related to one-off adjustments to the organisation) related to wages and salaries, social security and other charges, depreciation of property, plant and equipment, and other operating expenses Own cost supports in optimising organisational cost structures effectively and enhancing operational efficiency. Working capital Inventories, trade and other receivables less trade payables and other payables IMCD monitors its working capital ensuring effective resource allocation and operational liquidity for sustaining daily operations. 30